Standout Papers

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of <i>HER2</i>-Ov... 2002 2026 2010 2018 1.5k
  1. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer (2002)
    Charles L. Vogel, Melody Cobleigh et al. Journal of Clinical Oncology
  2. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience (2002)
    Andrew D. Seidman, Clifford A. Hudis et al. Journal of Clinical Oncology

Immediate Impact

8 by Nobel laureates 15 from Science/Nature 77 standout
Sub-graph 1 of 17

Citing Papers

A view on drug resistance in cancer
2019 StandoutNature
Therapeutic T cell engineering
2017 StandoutNature
2 intermediate papers

Works of Maureen Murphy being referenced

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout

Author Peers

Author Last Decade Papers Cites
Maureen Murphy 2255 108 764 1167 6 2.9k
Stanford J. Stewart 2481 185 762 1473 14 3.4k
Adam Knott 3085 125 607 1396 33 4.0k
Marion Procter 2214 140 665 836 34 2.7k
Scott N. Holden 2208 287 277 810 42 3.6k
Deborah Lindquist 2460 87 118 792 22 2.9k
Claire Barton 1997 193 127 676 39 2.7k
Lisa A. Damico 1215 138 149 1181 33 3.7k
Steven Stein 2973 131 111 978 20 3.6k
Steven R. Olsen 3008 128 89 1372 23 3.9k
Jayantha Ratnayake 2159 283 94 826 14 2.7k

All Works

Loading papers...

Rankless by CCL
2026